Physician profile
James Eby
NPI 1437101524
$5,762.94
in general payments reported to CMS, 2019-2025
12 companies · $2,306 in 2025
The $2,306 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.19 · 2021: $26.79 · 2022: $390 · 2023: $831 · 2024: $2,197 · 2025: $2,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,259 · Travel and Lodging: $74.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,259.01 |
| Travel and Lodging | $74.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,047.72 | 2023-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies |
| Abbott Laboratories | $780.59 | 2021-2025 | Proclaim, Eterna |
| Nevro Corp. | $678.23 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $423.06 | 2024-2025 | Evoke |
| Medtronic, INC. | $339.64 | 2024 | Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $202.23 | 2024-2025 | Mild Device Kit |
| Globus Medical, INC. | $171.35 | 2025 | Senza |
| Nalu Medical, INC. | $34.45 | 2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $33.09 | 2024 | Mild Device Kit |
| Djo, LLC | $22.88 | 2023 | Cmf |
| Spr Therapeutics, INC | $17.51 | 2025 | Sprint Pns System |
| Pacira Therapeutics, INC. | $12.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Eby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.